Lilly loses a heated patent row with the Canadian government
An international tribunal sided against Eli Lilly in a closely watched claim that the drug maker brought against the Canadian government over its right to set patent laws.
The dispute centered on different Canadian court rulings several years ago that invalidated patents on two Lilly drugs. Those decisions prompted the arrival of cheaper generics on the Canadian market, which Lilly claims led to “significant” sales and job losses in Canada.
